These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38749177)

  • 21. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
    Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
    Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease.
    Cong J; Zhou P; Zhang R
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet-Microbiota-Brain Axis in Alzheimer's Disease.
    Kincaid HJ; Nagpal R; Yadav H
    Ann Nutr Metab; 2021; 77 Suppl 2(Suppl 2):21-27. PubMed ID: 33906194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential.
    Qu L; Li Y; Liu F; Fang Y; He J; Ma J; Xu T; Wang L; Lei P; Dong H; Jin L; Yang Q; Wu W; Sun D
    Aging Dis; 2024 May; 15(3):1108-1131. PubMed ID: 37728579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dietary components on intestinal short-chain fatty acids (SCFAs) synthesis in healthy adult persons following a ketogenic diet.
    Gudan A; Skonieczna-Żydecka K; Palma J; Drozd A; Stachowska E
    Rocz Panstw Zakl Hig; 2022; 73(1):51-69. PubMed ID: 35322958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Wu Y; Hang Z; Lei T; Du H
    Neurochem Res; 2022 Dec; 47(12):3565-3582. PubMed ID: 36309938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
    Silva YP; Bernardi A; Frozza RL
    Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary neoagarotetraose extends lifespan and impedes brain aging in mice via regulation of microbiota-gut-brain axis.
    Li T; Yang S; Liu X; Li Y; Gu Z; Jiang Z
    J Adv Res; 2023 Oct; 52():119-134. PubMed ID: 37085001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of short-chain fatty acids in microbiota-gut-brain communication.
    Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
    Sajdel-Sulkowska EM
    Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
    Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
    Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
    Guo B; Zhang J; Zhang W; Chen F; Liu B
    Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of short-chain fatty acids in central nervous system diseases.
    Dong Y; Cui C
    Mol Cell Biochem; 2022 Nov; 477(11):2595-2607. PubMed ID: 35596843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.